Alice Lione – Pagina 7 – AMD

Alice Lione

Aprile 22, 2025 Alice Lione

Blood pressure lowering efficacy of dual glucose-dependent insulinotropic polypeptide/glucagon-like peptide-1 (GIP/GLP-1) receptor agonists compared to glucagon-like peptide-1 (GLP-1) receptor agonists

Grenet G, Gougeon A, Salzwedel DM, et al.
Cochrane Database Syst Rev. 2025;4(4):CD016144.

Leggi

Aprile 22, 2025 Alice Lione

Glucagon-like peptide-1 receptor agonists and sodium-glucose co-transporter-2 inhibitors combination therapy for adults with type 2 diabetes mellitus: a network meta-analysis

Osman AA, Tayeb BA, Metzendorf MI, et al.
Cochrane Database Syst Rev. 2025;4(4):CD015952.

Leggi

Aprile 22, 2025 Alice Lione

Gut microbiome research: revealing the pathological mechanisms and treatment strategies of type 2 diabetes

Fang X, Zhang Y, Huang X, et al.
Diabetes Obes Metab. Pub. online 15 Apr 2025.

Leggi

Aprile 22, 2025 Alice Lione

Comparative efficacy and safety of pharmacologic therapies for metabolic dysfunction-associated steatotic liver disease over 24 weeks in reducing liver steatosis and fibrosis: a network meta-analysis

Zhong J, Cai Z, Zhu G, Zhang J
Diabetes Obes Metab. Pub. online 10 Apr 2025.

Leggi

Aprile 22, 2025 Alice Lione

Trends in utilization of glucose- and weight-lowering medications after tirzepatide approval in the United States: a population-based cohort study

Ostrominski JW, Ortega-Montiel J, Tesfaye H, et al.
Ann Intern Med. Pub. online 15 Apr 2025.

Leggi

Aprile 22, 2025 Alice Lione

Timing of eating and glycemic control during pregnancy: a systematic review

Boege HL, Park C, Gagnier R, et al.
Nutr Metab Cardiovasc Dis. Pub. online 16 Apr 2025.

Leggi

Aprile 23, 2025 Alice Lione

Webinar “I nuovi Annali AMD 2024” – 28 maggio 2025

Leggi

Aprile 17, 2025 Alice Lione

GLI AUGURI DI AMD

Leggi

Aprile 17, 2025 Alice Lione

Persistence with once-weekly glucagon-like peptide 1 receptor agonist therapy decreases the risk of major adverse cardiovascular events: a retrospective analysis of patients with type 2 diabetes mellitus and atherosclerotic cardiovascular disease

Dunn TJ, Zhu Y, Gronroos NN, et al.
Diabetes Res Clin Pract. 2025:112162.

Leggi

Aprile 17, 2025 Alice Lione

FDA Warns Consumers Not to Use Counterfeit Ozempic (semaglutide) Found in U.S. Drug Supply Chain

14/04/2025

Leggi